National Technology Enterprises Company (NTEC) participated in the New Kuwait Summit as a bronze sponsor, the two-day event was held on the 10th and 11th of December 2019 at Sheikh Jaber Al-Ahmad Cultural Centre.
The conference was attended by various NTEC subsidiaries, including Kuwait Life Sciences Company (KLSC), CEOs and directors provided a global platform and window to the world to attract insightful debate and information around the seven pillars identified by the Kuwait National Development Plan; Kuwait's Global Position, Infrastructure, Human Capital, Public Administration, Healthcare, Economy and Living Environment.
Built around a world-class conference program led by Government and industry leaders and experts, the New Kuwait Summit allowed international and domestic companies to network, engage and create partnerships.
Kuwait Life Sciences (KLSC) was established in 2010, with a paid up capital of 18 million Kuwait Dinars (KD) which is equivalent to approximately $60 million US Dollars. KLSC is fully owned by National Technology Enterprises Company. National Technology Enterprises Company (NTEC) was incorporated in November of 2002, by the Kuwait Council of Ministers as a fully owned company by the Kuwait Investment Authority (KIA), the sovereign wealth fund of the State of Kuwait. Capitalized at 100 million Kuwait Dinars (KD) which is equivalent to approximately $350 million US Dollars, NTEC aims to play a vital role in servicing major stakeholders in Kuwait and the Middle East region with their technology requirements.
KLSC focuses on healthcare innovative concepts and demanded services which have a clear and unmet need in the Middle East and North Africa (MENA) region. KLSC has been designed as an integrated healthcare company building unique projects and is considered one of the pioneer venture capitalist and private equity companies in the Middle East that invests globally and operates regionally seeking to advance healthcare services and systems within the region. KLSC supports both public and private sector stakeholders to access emerging technologies, establish unique projects and adopt best practices prevailing in today’s healthcare field. KLSC operates in healthcare investment, life sciences training, medical technology, and pharmaceutical distribution.
For Further Press Enquiries:
Email KLSC at: firstname.lastname@example.org
Our mailing address is:
KIPCO Tower, 27th floor, Block 9
Al Shohadaa Street, Sharq
P.O.Box 25363, Safat 13114 Kuwait
© Press Release 2019
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.